Patent details

EP2190429 Title: A NOVEL GROUP OF STAT3 PATHWAY INHIBITORS AND CANCER STEM CELL PATHWAY INHIBITORS

Basic Information

Publication number:
EP2190429
PCT Application Number:
PCT/US/2008/075903
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP088306196
PCT Publication Number:
WO/2009/036099
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
A NOVEL GROUP OF STAT3 PATHWAY INHIBITORS AND CANCER STEM CELL PATHWAY INHIBITORS
French Title of Invention:
GROUPE INNOVANT D'INHIBITEURS DE LA VOIE STAT3 ET D'INHIBITEURS DE LA VOIE DES CELLULES SOUCHES CANCÉREUSES
German Title of Invention:
NEUE GRUPPE VON STAT3-PFAD-HEMMERN UND KREBS-STAMMZELL-PFAD-HEMMER
SPC Number:

Dates

Filing date:
10/09/2008
Grant date:
20/04/2016
EP Publication Date:
20/04/2016
PCT Publication Date:
19/03/2009
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
02/06/2010
EP B1 Publication Date:
20/04/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
10/09/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
10/09/2008
 
 

Name:
Boston Biomedical Inc.
Address:
640 Memorial Drive, Cambridge, MA 02139, United States (US)

Agent

Name:
STOLMÁR & PARTNER
From:
19/04/2016
Address:
BLUMENSTR. 17, 80331, MÜNCHEN, Germany (DE)
To:

Inventor

1

Name:
JIANG Zhiwei
Address:
United States (US)

2

Name:
LI Youzhi
Address:
United States (US)

3

Name:
LI Chiang, Jia
Address:
United States (US)

4

Name:
LIU Jifeng
Address:
United States (US)

5

Name:
LI Wei
Address:
United States (US)

6

Name:
ROGOFF Harry
Address:
United States (US)

Priority

1

Priority Number:
971144 P
Priority Date:
10/09/2007
Priority Country:
United States (US)

2

Priority Number:
13372
Priority Date:
13/12/2007
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/505;

Annual Fees

Annual Fee Due Date:
30/09/2026
Annual Fee Number:
19
Annual Fee Amount:
281 Euro
Expected Payer:
Last Annual Fee Payment Date:
09/09/2025
Last Annual Fee Paid Number:
18
Last Annual Fee Paid Amount:
262 Euro
Payer:
Beijing Guozhuan Intellectual Property Ltd
Filing date Document type Number of pages